Boehringer Ingelheim GmbH - SWOT Analysis
| Publication Date | June 2008 |
|---|---|
| Publisher | Datamonitor |
| Product Type | Report |
| Pages | 29 |
| ISBN Number | not applicable |
| Product Code | DAT05630 |
Summary
Boehringer Ingelheim GmbH - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Boehringer Ingelheim (Boehringer) is a group of privately held companies. The company is engaged in the research, development, manufacture and marketing of human pharmaceuticals, biopharmaceuticals, chemicals and animal health products. The company operates in Europe, the Americas, Asia, Australasia and Africa. The company is headquartered in Ingelheim, Germany and employs about 39,800 people. The company recorded revenues of E11,584 million (approximately $15,878.6 million) during the fiscal year ended December 2007, an increase of 3.6% over 2006. The operating profit of the company was E2,100 million (approximately $2,878.5 million) during fiscal year 2007, a decrease of 1.9% over 2006. The net profit was E1,809 million (approximately $2,479.6 million) in fiscal year 2007, an increase of 5.1% over 2006. Conversion has been calculated using a 2007 average conversion rate of 1 Euro = $1.37074. (http://www.oanda.com)
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers' businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors' business structure, strategy and prospects
- Obtain the most up to date company information available
Content
- This Product Typically Includes The Following Sections:
- Key Facts
- Company Overview
- Business Description
- Company History
- Key Employees
- Key Employee Biographies
- Company View
- Swot Analysis
- Products & Services Listing
- Products & Services Analysis
About this Product
Delivery Details
PDF:Delivered by email usually within 4 to 8 UK business hours.
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















